Results 231 to 240 of about 283,224 (387)

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

New England Journal of Medicine, 1990
C. Moertel, T. Fleming, J. Macdonald, D. Haller, J. Laurie, P. Goodman, J. Ungerleider, W. Emerson, D. Tormey, J. Glick, M. Veeder, J. Mailliard   +11 more
semanticscholar   +1 more source

Ineffectiveness of pioglitazone in cognitive impairment induced by cyclophosphamide, methotrexate, and fluorouracil via oxidative stress and neuroinflammation. [PDF]

Front Neurosci
Alhowail AH.
europepmc   +1 more source

Comparison of 5-fluorouracil with 5-fluorouracil, cyclophosphamide, and methotrexate in metastatic colorectal carcinoma [PDF]

, 1975
Frederick Richards, Thomas Pajak, M. Robert Cooper, Charles L. Spurr   +3 more
openalex   +1 more source

Efficacy of perioperative and neoadjuvant therapies in gastric and gastroesophageal junction adenocarcinoma: a network meta-analysis. [PDF]

Oncologist
Anjum MU, Naqvi SAA, Jajja SA, Raina A, Afzal MU, Faisal KS, Segovia D, Jin Z, Yoon HH, Uson Junior PLS, Starr J, Ahn DH, Bekaii-Saab TS, Riaz IB, Sonbol MB.   +14 more
europepmc   +1 more source

Metabolism of 5-fluorouracil in sensitive and resistant Novikoff hepatoma cells.

, 1977
David S. Wilkinson, Jeanne Crumley
openalex   +1 more source

Cycloaddition and Annulation Reactions with Donor‐Acceptor Cyclobutanes

Helvetica Chimica Acta, EarlyView.
Reviewing the rise of donor‐acceptor cyclobutanes in (4 + 2) annulations, from Lewis/Brønsted acid to electrocatalysis, enabling stereoselective access to complex heterocycles and natural products. Abstract Donor‐acceptor (DA) cyclobutanes are emerging as valuable synthetic intermediates due to their ring strain and polarized C─C bonds, which allow for
Emma G. L. Robert, Jerome Waser
wiley   +1 more source

Letter to the editor re: CDX2 expression as a predictive and prognostic biomarker of 5-fluorouracil response in cancer of unknown primary. [PDF]

ESMO Open
Krämer A.
europepmc   +1 more source

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

New England Journal of Medicine, 2007
J. Vermorken, É. Remenár, C. V. van Herpen, T. Gorlia, R. Mesía, M. Degardin, J. Stewart, S. Jelić, J. Betka, J. Preiss, D. van den Weyngaert, A. Awada, D. Cupissol, H. Kienzer, A. Rey, Isabelle Desaunois, J. Bernier, J. Lefebvre   +17 more
semanticscholar   +1 more source

Adjuvant FLOT provides survival benefit for oesophagogastric junction and gastric adenocarcinoma patients with low tumour regression after neoadjuvant chemotherapy

International Journal of Cancer, EarlyView.
What's New? Perioperative FLOT, a chemotherapy regimen consisting of docetaxel, oxaliplatin, leucovorin and 5‐fluorouracil, is the standard treatment for oesophagogastric junction and gastric adenocarcinoma (OGA). Whether patients benefit further from adjuvant FLOT, given postoperatively, is uncertain.
Max Kraemer, Naita M. Wirsik, Hakan Alakus, Hans A. Schloesser, Hans Fuchs, Wolfgang Schroeder, Christiane J. Bruns, Su Ir Lyu, Friederike Baehr, Thomas Zander, Alexander Quaas   +10 more
wiley   +1 more source

Successful Management of Esophageal Sarcomatoid Carcinoma with Neoadjuvant Chemotherapy and Esophagectomy. [PDF]

Surg Case Rep
Yokota K, Kitagawa H, Araki K, Shinno K, Namikawa T, Seo S.   +5 more
europepmc   +1 more source